| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 82.97B | 84.41B | 82.11B | 83.86B | 80.14B | 84.92B |
| Gross Profit | 20.62B | 20.17B | 16.73B | 18.34B | 21.05B | 17.22B |
| EBITDA | 10.08B | 9.85B | 7.42B | 8.96B | 11.96B | 8.68B |
| Net Income | 4.87B | 5.01B | -7.09B | 2.34B | 6.75B | -2.80B |
Balance Sheet | ||||||
| Total Assets | 123.36B | 123.32B | 125.44B | 128.02B | 123.92B | 123.01B |
| Cash, Cash Equivalents and Short-Term Investments | 16.39B | 16.42B | 16.71B | 12.41B | 10.88B | 11.41B |
| Total Debt | 22.98B | 21.92B | 27.04B | 21.64B | 16.96B | 20.44B |
| Total Liabilities | 45.67B | 43.93B | 49.98B | 43.30B | 41.21B | 43.74B |
| Stockholders Equity | 76.64B | 78.29B | 74.39B | 80.49B | 78.85B | 75.81B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.06B | 2.84B | -1.89B | 1.50B | -1.74B |
| Operating Cash Flow | 0.00 | 12.01B | 6.87B | 773.00M | 6.57B | 7.83B |
| Investing Cash Flow | 0.00 | -5.71B | -3.96B | -2.62B | -1.65B | -7.42B |
| Financing Cash Flow | 0.00 | -6.88B | 1.26B | 3.28B | -5.65B | 1.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥79.53B | 11.63 | 15.07% | 1.74% | 15.12% | 40.72% | |
75 Outperform | ¥54.38B | 16.36 | ― | 2.92% | 3.03% | 28.27% | |
73 Outperform | ¥59.22B | 18.37 | 6.31% | 4.01% | 6.38% | 22.81% | |
70 Outperform | ¥83.56B | 10.34 | ― | 3.74% | -0.68% | -9.93% | |
70 Outperform | ¥55.02B | -468.17 | ― | 4.37% | -1.09% | ― | |
66 Neutral | ¥22.90B | 5.80 | ― | 4.62% | 7.19% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |